PhD

Duke Haddad, Ed.D., CFRE, is currently associate director of development, director of capital campaigns and director of corporate development for The Salvation Army Indiana Division in Indianapolis. He also serves as president of Duke Haddad and Associates LLC and is a freelance instructor for Nonprofit Web Advisor.

He has been a contributing author to NonProfit PRO since 2008.

He received his doctorate degree from West Virginia University with an emphasis on education administration plus a dissertation on donor characteristics. He received a master’s degree from Marshall University with an emphasis on public administration plus a thesis on annual fund analysis. He secured a bachelor’s degree (cum laude) with an emphasis on marketing/management. He has done post graduate work at the University of Louisville.       

Duke has received the Fundraising Executive of the Year Award, from the Association of Fundraising Professionals Indiana Chapter. He also was given the Outstanding West Virginian Award, Kentucky Colonel Award and Sagamore of the Wabash Award from the governors of West Virginia, Kentucky and Indiana, respectively, for his many career contributions in the field of philanthropy. He has maintained a Certified Fund Raising Executive (CFRE) designation for three decades.

As you progress in your knowledge of fundraising, the importance of the concept of blending will come into play. The idea of blending gifts needs to begin with donor research.

LIVERMORE, CA, October 29, 2009 — The Fannie and John Hertz Foundation announced today that Jay Davis, PhD, has been elected President of the Hertz Foundation. Dr. Davis, the Founding Director of the Defense Threat Reduction Agency (DTRA) and the Founding Director of the Center for Accelerator Mass Spectrometry at Lawrence Livermore National Laboratory (LLNL), currently serves on the Board of Directors of the Hertz Foundation. The Hertz Foundation, established in 1957, is one of the nation’s leading non-profit organizations focused on empowering innovative young scientists and engineers.

June 25, 2009 — As of mid-2009, The Michael J. Fox Foundation for Parkinson’s Research has already funded over $1 million in high-risk, high-reward approaches to Parkinson’s therapeutic development through its groundbreaking Rapid Response Innovation Awards. Projects include investigations of the safety and efficacy of an FDA-approved drug for kidney disease to treat Parkinson’s; characterization of a tenuous link between PD and certain strains of influenza virus; and a proof-of-principle approach to refine deep brain stimulation (DBS) into a potentially more effective symptomatic therapy.

More Blogs